Analysis of genotypes combinations at the polymorphic points of the promoter regions of the genes of three matrix metalloproteinases and the gene of vascular endothelial growth factor (VEGF) in patients with prior acute myocardial infarction


Cite item

Full Text

Abstract

AIM: To analyze the association of the promoter polymorphism of the genes of the matrix metalloproteinases (MMP) MMP2 (–1306), MMP3 (–1171), and MMP9 (–1562) and two vascular endothelial growth factor (VEGF) gene regulatory regions (–2578, +936) with the development of myocardial infarction (MI). Materials and methods. DNA was analyzed in 251 patients with a history of MI. Five polymorphic positions were genotyped by restrictase analysis of amplification products, by using specific primers/RESULTS: In addition to the MMP3 5A5A monogenotype, there were 4 complex genotypes that were significantly different between two analyzed groups and positively associated with acute coronary syndrome. Among them, each of two genotypes included 2 polymorphic positions; two genotypes did 3 analyzed polymorphic positions. Four complex (two-locus (n=1), three-locus (n=2), four-locus (n=1) genotypes that were negatively associated with MI were also identified./CONCLUSION: These findings are evidence in favor of our assumption that the increasing number of genotypes as part of the analyzed combined genetic complexes detectable in one patient considerably enhances the clinical significance of the results of immunogenetic analysis.

About the authors

A V Shevchenko

ФГБУ "Научно-исследовательский институт клинической и экспериментальной лимфологии" СО РАМН, Новосибирск; ФГБУ "Новосибирский НИИ патологии кровообращения им. акад. Е.Н. Мешалкина" СО РАМН

Email: shalla64@mail.ru

V I Konenkov

ФГБУ "Научно-исследовательский институт клинической и экспериментальной лимфологии" СО РАМН, Новосибирск; ФГБУ "Новосибирский НИИ патологии кровообращения им. акад. Е.Н. Мешалкина" СО РАМН

Email: konenkov@soramn.ru

V F Prokof'ev

ФГБУ "Научно-исследовательский институт клинической и экспериментальной лимфологии" СО РАМН, Новосибирск; ФГБУ "Новосибирский НИИ патологии кровообращения им. акад. Е.Н. Мешалкина" СО РАМН

Email: vprok@ngs.ru

E A Pokushalov

ФГБУ "Новосибирский НИИ патологии кровообращения им. акад. Е.Н. Мешалкина" СО РАМН

References

  1. Панченко Е.П. Механизмы развития острого коронарного синдрома. РМЖ 2000; 8: 359-370.
  2. Creemers E., Cleutjens J., Smits J., Daemen M. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 2001; 89: 201-210.
  3. Shah P. Plaque disruption and thrombosis: potential role of inflamemation and infection. Cardiol Rev 2000; 8: 31-39.
  4. Beyzade S., Zhang S., Wong Y. et al. Influences of Matrix Metalloproteinase-3 Gene Variation on Extent of Coronary Atherosclerosis and Risk of Myocardial Infarction. J Am Coll Cardiol 2003; 41: 2130-2137.
  5. Kliche S., Waltenberger J. VEGF receptor signaling and endothelial function IUBMB Life 2001; 52 (1-2): 61-66.
  6. Tsiamis A., Morris P., Marron M., Brindle N. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc Res 2002; 63 (2): 149-158.
  7. Wagner S., Fueller T., Hummel V. et al. Influence of VEGF-R2 inhibition on MMP secretion and motility of microvascular human cerebral endothelial cells (HCEC). J Neurooncol 2003; 62: 221-231.
  8. Dias S., Hattori K., Zhu Z. et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 2000; 106: 511-521.
  9. Deryugina E., Quigley J. Pleiotropic roles of matrix metalloproteases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta 2010; 1803: 103-120.
  10. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
  11. Chow A., Cena J., Schulz R. Acute actions and novel targets of matrix metalloproteases in the heart and vasculature. Br J Pharmacol 2007; 152: 189-205.
  12. Funahashi Y., Shawber C., Sharma A. et al. Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activityVasc Cell 2011; 3: 2.
  13. Lamblin N., Bauters Ch., Hermant X. et al. Polymorphisms in the Promoter Regions of MMP-2, MMP-3, MMP-9 and MMP-12 Genes as Determinants of Aneurysmal Coronary Artery Disease. J Am Coll Cardiol 2002; 40 (1): 43-48.
  14. Pollanen P., Lehtimaki T., Mikkelsson J. et al. Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. Atherosclerosis 2005; 180: 73-78.
  15. Howell W., Ali S., Rose-Zerilli M., Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet 2005; 42: 485-490.
  16. Shahbazi M., Fryer A., Pravica V. et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13: 260-264.
  17. Renner W., Kotschan S., Hoffmann C. et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37: 443-448.
  18. Шевченко А.В., Коненков В.И., Голованова О.В. и др. Полиморфизм гена VEGFA (С-2578A, C+936T) у пациенток с раком молочной железы. Мед иммунол 2012; 14 (1-2): 87-94.
  19. Шевченко А.В., Голованова О.В., Коненков В.И. и др. Анализ полиморфизма генов матриксных металлопротеиназ-2 и -9 у пациентов с ишемической болезнью сердца. Тер арх 2010; 1: 31-35.
  20. Takahashi M., Haro H., Wakabayashi Y. et al. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J Bone Joint Surg 2001; 83-B: 491-495.
  21. Бабич П.Н., Чубенко А.В., Лапач С.Н. Применение современных статистических методов в практике клинических исследований. Сообщение третье. Отношение шансов: понятия, вычисление и интерпретация. Украинский мед журн 2005; 2: 113-119.
  22. Ластед Л. Введение в проблему принятия решений в медицине. М: Мир 1971; 282.
  23. Юнкеров В.И., Григорьев С.Г. Математико-статистическая обработка данных медицинских исследований. СПб: ВМедА 2002; 266.
  24. Вейр Б. Анализ генетических данных. Дискретные генетические признаки. Пер с англ. М: Мир 1995.
  25. Glantz S.A. Medical and biological statistics. Translated from English. M: Practice 1998; 459.
  26. Terashima M., Akita H., Kanazawa K. et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 1999; 99: 2717-2719.

Copyright (c) 2014 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies